Publicaciones en colaboración con investigadores/as de Semmelweis University (11)

2021

  1. Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 11, pp. 785-798

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial

    BMC Cancer, Vol. 21, Núm. 1

  4. Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study

    Arthritis and Rheumatology, Vol. 73, Núm. 2, pp. 336-346

2019

  1. Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition

    JCO Precision Oncology

2018

  1. Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma

    New England Journal of Medicine, Vol. 378, Núm. 6, pp. 518-528

2017

  1. Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas

    Journal of Clinical Oncology, Vol. 35, Núm. 25, pp. 2934-2941

2016

  1. Teenagers and young adults with cancer in Europe: From national programmes to a European integrated coordinated project

    European Journal of Cancer Care, Vol. 25, Núm. 3, pp. 419-427

  2. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis

    Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477

2012

  1. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065

2010

  1. Barriers to the development of palliative care in Western Europe

    Palliative Medicine, Vol. 24, Núm. 8, pp. 812-819